Elon Musk’s Neuralink has been making significant progress. Recently, the company announced that it has begun human clinical trials for its brain-machine interface (BMI) technology. The goal is to develop implantable chips that can treat a range of medical conditions, including paralysis, depression, and anxiety.
In a recent update, Musk stated that Neuralink’s technology has successfully allowed a monkey to control a computer with its mind. The company is also working on developing a robotic system that can implant the chips with high precision, reducing the risk of surgical complications.
Musk aims to make Neuralink’s technology widely available, with a potential price point of around $1,000 per procedure. He believes that the technology could eventually be used to enhance human cognition and potentially even achieve a symbiosis between humans and AI. With human trials underway, Neuralink is one step closer to making this vision a reality.
💬 Answers 1